Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors

作者: Valeria S. Ossovskaya , Charles Bradley , Barry M. Sherman

DOI:

关键词:

摘要: In one aspect, the present invention provides a composition and kit comprising combination of topoisomerase inhibitor PARP for treatment cancer. another method treating cancer administering to subject inhibitor. particular, compositions methods in by inhibiting poly-ADP-ribose polymerase topoisomerase, as well providing formulations modes such compositions.

参考文章(69)
Jerome Mendeleyev, Ernest Kun, Eva Kirsten, Synergistic compositions useful as anti-tumor agents ,(1995)
Sydney Shall, Manoochehr Tavassoli, Substituted benzene compounds ,(1995)
Valeria Ossovskaya, Barry Sherman, John Burnier, Max Totrov, Drug design for tubulin inhibitors, compositions, and methods of treatment thereof ,(2007)
Zdenek Hostomsky, Ian J. Stratford, Kaye Janine Williams, Huw David Thomas, David Richard Newell, Elizabeth Ruth Plummer, Steven David Reich, Christopher Jones, Nicola Jane Curtin, Heidi Marie Steinfeldt, Theodore James Boritzki, Karen J. Klamerus, Alan Hilary Calvert, Rhonda Kaufman, Mohamed Raza Dewji, Therapeutic combinations comprising poly (ADP-ribose) polymerases inhibitor ,(2005)
Jerome Mendeleyev, Hassan Lemjabbar-Alaoui, Carol Basbaum, Ernest Kun Kun, Valeria Ossovskaya, Treatment of Cancer ,(2006)
Zhen-Ping Wu, Mark Bryan Mitchell, Ming Guo, Naresh Nayyar, Jia Liu, Jan-Jon Chu, Yi Li, Bennett Chaplin Borer, Aparna Nadig Srirangam, Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one ,(2005)